Skip to main content

Table 2 Results of esophagogastroduodenoscopy in the enrolled patients

From: Safety of esophagogastroduodenoscopy-guided forceps biopsy and the feasibility of esophagogastroduodenoscopy for evaluation of hypopharyngeal cancer

Patient number

Sex

Age range

(years)

Sedation

Location

Histologic diagnosis using EGD forceps

Complication

Passage of scope

Number of biopsied tissue fragments

Concomitant upper gastrointestinal disease

00298963

male

65–70

+

posterior pharyngeal wall and pyriform sinus

no

yes

0

reflux esophagitis, gastric polyp, duodenal ulcer active stage

00298607

male

60–65

pyriform sinus

squamous cell carcinoma

no

yes

4

atrophic gastritis, intestinal metaplasia

00272563

male

60–65

pyriform sinus

squamous cell carcinoma

no

yes

3

duodenal polyp

00164374

male

75–80

+

pyriform sinus

squamous cell carcinoma

no

yes

3

atrophic gastritis, intestinal metaplasia

00294335

male

85–90

+

pyriform sinus

a few necrotic atypical squamous cells

no

noa

3

atrophic gastritis, intestinal metaplasia

00252398

male

50–55

+

postcricoid area

squamous cell carcinoma

no

yes

2

Gastric ulcer scar

00247856

male

80–85

+

posteriorpharyngeal wall

squamous cell carcinoma

no

yes

3

 

00225664

male

60–65

posterior pharyngeal wall

no

yes

0

esophageal candidiasis

00176506

male

75–80

posterior pharyngeal wall/postcricoid area

no

no

0

 
  1. EGD esophagogastroduodenoscopy, aUltrathin scope passed through the pyriform sinus